Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to estimate the effect of preoperative gefitinib on the complete
pathological response rate in primary estrogen receptor negative breast cancer at the time of
surgery.